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Brain injury is the major cause of death after hospital admission in patients who are admitted following successful resuscitation from an out-of-hospital cardiac arrest (OHCA). 1 Mild induced hypothermia to 32-34°C is recommended as a neuro-protective strategy [2] [3] [4] for patients who remain comatose after hospital admission. Recently, the Target Temperature Management after out-of-hospital cardiac arrest (TTM)-trial 5 found no benefit for survival or crude neurological function when targeting a temperature of 33°C compared to 36°C during an intervention period of 36 hours.
Considering the impact of brain injury on survival after cardiac arrest, severe neurological impairment is rare among survivors, with as many as 90% achieving good longterm neurological outcome according to the commonly used Cerebral Performance Categories (CPC) scale. [6] [7] [8] Despite a good outcome according to CPC, cognitive difficulties may nevertheless be prevalent as reported in several smaller studies using neuropsychological tests. 9, 10 In a recent review, 30-50% of survivors from cardiac arrest were reported to suffer from cognitive impairment. 11 The generalizability of previous studies is poor due to small sample sizes [12] [13] [14] , missing data 13, 14 and patient selection excluding those with a poor outcome, 14 including only patients with severe symptoms 12 or absence of a non-arrest control group.
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Optimally OHCA-survivors should be evaluated for the cognitive functions known to be most affected; memory, attention and executive functions. 11, 15 One small study, within the Hypothermia after Cardiac Arrest-trial 2 evaluated the effects of induced hypothermia against no temperature management and reported no statistically significant differences between the two intervention groups, but a tendency towards more favourable results for hypothermia-treated patients. 9 In this study we hypothesized primarily that, due to possible neuro-protective effects, erm neurological outcome according to the commonly used Cerebral Performanc nc ce Ca Ca ate te ego go gori ri ries es CPC) scale. [6] [7] [8] Despite a good outcome according to CPC, cognitive difficulties may ne eve ve vert rt rthe he hele le less ss s b b be pr pr pre ev evalent as reported in several sm sm sma a aller studies us s sin i i g ne ne neu ur uropsychological tests. 9 , 0 0 0 In n n a recent r rev ev vie ew, w, 3 3 30-0--50 50 50% % % o of of s s sur ur urvi viv vo vors f fr ro rom m ca ar rd dia ac c ar arr re es st t w wer ere e re rep p por rted ed d t t to o su suff ff ffer er e f f fro o om m m co ogn gn gnit it itiv iv i e e im im mp pa pair irme ment nt. . 11 T The he g g gen en ner er eral al aliz izab ab abil il ilit it ity y y of of of p p pr re rev v vio ou ous s s st st stud ud udie ie ies s is s p p poo oo or d du due e e to to o s sma ma mal ll ll s sam am ampl ple e e izes 12 12 12-14 14 14 , mi iss ss sin in ng g g da da data ta a 13 13 13, 14 14 14 a a and n n p p pat at a ie ie ent nt s s sel el elec ec ecti ti ion on on e e exc xc xclu lu l di di ing ng ng t tho ho hose se se w wit it ith h h a a a po po poor or o o o out ut utco co come me me, 14 14 14 by guest on March 31, 2017 http://circ.ahajournals.org/ Downloaded from cognitive impairment would be less pronounced in patients treated with 33 C compared to those treated with 36 C, and secondarily that both groups (33°C and 36°C) of OHCA-survivors would have more cognitive impairment than a group of control patients matched for important riskfactors.
Methods

Study design
The protocol for this pre-defined study in the TTM-trial (ClinicalTrials.gov: NCT01020916) was published 16 and registered at ClinicalTrials.gov: NCT01946932. Patients were randomized, stratified for site, to targeted temperature management of 33°C or 36°C after cardiac arrest with a total intervention period of 36 hours. 5, 17 Patients surviving to hospital discharge were invited to a face-to-face follow-up at approximately 180 days post-arrest to complete the neurological outcome assessments of the main trial. [16] [17] [18] At these follow-up visits patients at 20 out of 36 sites in five European countries (Sweden, Denmark, the Netherlands, Italy, and United Kingdom) participated in this study. Matched control-patients completed the same assessments as the OHCA-survivors. Examiners were blinded for the targeted temperature management allocation but not whether the patient was a control. The follow-up meetings were performed from June 2011 to September 2013. All participating centres had ethical approval for the TTM-trial with additional approval for this study. Written informed consent was obtained before follow-up.
Setting
The face-to-face follow-up was primarily performed at the participating institutions. If a patient was unable to visit the institution, the follow-up was performed in the patient's home/nursing home. Examiners were an occupational therapist, a psychologist, a research nurse or a physician.
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The tests were administered in a defined order, pre-specified in a written study manual.
Examiners attended training and follow-up meetings. The study coordinator performed regular monitoring and provided support.
Study population
Within the TTM-trial 5 unconscious patients 18 years or older with OHCA of a presumed cardiac origin irrespective of initial rhythm were randomized at hospital arrival to targeted temperature management at either 33°C or 36°C. The randomisation and inclusion process has been described previously. 5, 16, 17 For the present study, control patients were recruited with an intended 2:1 ratio where every second OHCA patient was matched to a control with a prespecified estimation of 120 patients in each group. The control population was recruited at one site in each country from a cohort of ST-elevation myocardial infarction patients (STEMI) treated with percutaneous coronary intervention, matched for age, gender, country and time-point of hospitalization (±two weeks). Socio-demographical and medical background variables were collected.
16
Outcome Assessment
Following the neurological tests of the main trial 17, 18 patients from the 33°C-group, the 36°C-group and the STEMI-control group performed cognitive tests 16 selected to assess the most commonly affected cognitive domains after OHCA: memory, attention, and executive function.
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In addition potential differences in psychological stress between the groups were tested.
Rivermead Behavioural Memory Test (RBMT) 19 evaluates memory functions needed in everyday life. The profile-score has pre-defined cut-off levels to grade the memory performance into normal (22) (23) (24) 
Statistical Analysis
Statistical analyses were performed on three levels. Level 1 embraces all randomized patients in the TTM-trial at the centres participating in this study (33ºC and 36ºC) and includes the deceased to avoid survival bias. Level 2 includes all patients surviving to follow up at the study centres. In the third exploratory level (level 3) only survivors that actually participated in the follow-up were analysed. STEMI-controls were included in the third level of analysis only.
Analysis level 1 (Figure 1 ): Differences in cognitive impairment between the two treatment groups measured by FAB, RBMT and SDMT were analysed with scores as a continuous variable using the non-parametric Mann-Whitney-Wilcoxon test, and the BonferroniHolm method to correct for multiple testing. Deceased patients were assigned a lower rank than the lowest rank of those observed, and multiple imputations (online-only Data Supplement) were performed for alive non-responders (not participating in the testing) and for missing data. A stratified analysis was performed to explore influences of country using the Kruskal-Wallis test.
normal.
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Statistical Analysis
St tat at tis is isti ti tic ca cal l l an an a a a alys ys ses es es w were performed on three leve ve el ls. . Level 1 embr rac a a es s a a all ll ll randomized patients in h h he T TTM-trial l at at th h he c cen entr t tres es es p p pa ar art tic ic cip ip ipat a i in ng g g in th h his st tu ud dy used as covariates in all adjusted models. Additionally, the adjusted model for FAB and RBMT included age and education as covariates, already adjusted for in the SDMT by conversion to zscores. Post-hoc analyses, with the false discovery rate to correct for multiplicity, was performed only if the overall test had a p-value <0.05. Descriptive data for the tests are presented for complete and imputed cases. An a priori sample size calculation showed >80% power to detect a 10% difference between the groups based on the RBMT profile score. 13 Statistical analyses were performed using SPSS 22.0 and R 3.10. 
Results
At the 20 participating sites 652 OHCA-patients were included from the TTM-trial with 328 randomized to the 33°C-group and 324 to the 36°C-group. All patients at each site were included. In the 33°C-group 150 patients died within the first 180 days, compared to 160 in the 36°C-group. Of survivors 287 (90% of patients alive and eligible to include, 84% of alive) participated in the face-to-face follow-up (148 in the 33 C-group and 139 in the 36 C-group) and were matched to 119 STEMI-control patients. The flowchart for inclusion in this study is shown in Figure 1 . Of all eligible patients 10% had a CPC 3-4, equal in both groups ( Figure 1 ) and 42% of these denied or were unable to participate in the follow-up. Consequently, a higher percentage of missing patients were severely impaired (42%) than participants (7%). Of STEMIpatients identified as possible controls (n=192), we were unable to contact 14% to ask for participation and an additional 24% declined. In total 38% of eligible controls were missing and most common reasons for not participating were: not interested, already participating in several studies or no time (e.g. working full-time).
Socio-demographic and medical background variables are presented for OHCA patients and the controls in Table 1 and 2 and were representative of the whole TTM-population (Supplemental Table 1 ). Among patients included in the level 3 analysis, individuals in the 33 C-group were slightly older, had less years of education, received less bystander cardiopulmonary resuscitation and more often had a history of ischemic heart disease and/or arrhythmia. All other pre-hospital variables were similar Levels of depressive and anxiety symptoms according to the HADS ( Table 2) did not differ between the three groups (p>0.30). Among patients that worked before the event, 46% of the OHCA-patients in both groups had returned to their previous level of occupation at the time percentage of missing patients were severely impaired (42%) than participants (7 7% 7%) ). ) O O Of f ST ST STEM EM E I-I patients identified as possible controls (n=192), we were unable to contact 14% to ask for pa art rt rtic ic icip ip ip t atio io ion n n a and d d a an an additional 24% declined. In n to to t t t tal 38% of eligi gi gibl b e e co co con n ntrols were missing and of follow-up vs. 72% of the controls (p=0.008), while 69% of the OHCA-patients versus 80% of the controls had returned to work in some degree (p=0.23). Among patients working at the time of the event 5% (n=7) of OHCA-patients vs. 10% (n=5) of STEMI-controls had retired.
In the primary analysis including dead and imputed patients (Figure 1 , level 1) the three tests; RBMT, FAB and SDMT were descriptively similar ( Table 3 ) and p-values indicated no statistically significant differences between the two temperature interventions with all test having a p-value > 0.30 (Supplemental Table 2 ), both when including and excluding deceased patients.
Stratification by country did not change these results.
In the exploratory comparisons of participants in the face-to-face follow up and controls RBMT-scores were similar for OHCA-patients and STEMI-controls ( Table 3) . No statistically significant group differences were found overall (unadjusted p=0.46/ adjusted p=0.06).
Executive dysfunction was detected by the FAB in 20-23% of OHCA-patients participating in the follow-up (Figure 3 ) compared to 13% of the controls. The analysis of the continuous FAB-score did not show any statistically significant difference between the three groups (unadjusted p=0.22). However, including the specified covariates there was a statistically significant difference (adjusted p=0.008). An interaction between group and country (p=0.017) was found and further post-hoc analyses showed a statistical significant difference between all cardiac arrest patients and STEMI-controls in Italy (Italy: 33 C /STEMI-controls p=0.01 and Figure 1 , level 3) approximately half of the OHCA-patients and controls obtain ned e ed a a n n nor or orma ma mal l l core at the memory assessment (RBMT) (Figure 2) . Less than 10% of the OHCA survivors had c cor or res es es c c com om mpa pa patibl bl le e e w with a severe memory disturb b ba a anc nc ce, but almost no n n ne e o o of f f the controls. When the co om mp mparison w was as ex xp xpan an nde de ed d d to to to i i inc nclu lu ud de de p p pa at tient ts with h h m mod od de er erat at te im imp pa pair irme ment nt 2 20% 0% 0% o of f OH OH OHCA CA C --p -pat at tie ie en nts ha had d d mo mo mode dera ra ate te te-s -se ev ve er ere e me me memo m ry ry y i i imp mp mpai ai airm rm men en nt t t a as as c c co o om mp mpa ar are ed d t t to o o 1 17 17% % % o of of t t the he h c c con n ntr tro ol ols. s. T The he he me e ean n n 36 C/STEMI-controls p=0.003) but no statistical significant difference between the two temperature groups (Italy; 33 C /36 C p=0.59). There were no significant differences found between any of the three groups in the other countries (p >0.30).
The two groups of OHCA-patients performed similarly but worse than STEMI-controls on the SDMT assessing mental speed and attention (Table 3) , and more than half of the OHCA population in Level 3 had low z-scores (<-1) (Figure 4) . The overall analysis of the SDMT detected a statistically significant difference between the three groups (unadjusted p<0.001).
Unadjusted post-hoc analyses showed a difference between the OHCA groups compared to the controls (33 C/STEMI-controls p=0.007, 36 C/STEMI-controls p<0.001) but no statistical significant difference between the two temperature groups (33 C/36 C p=0.65) Also the covariate-adjusted analysis revealed a statistically significant result (adjusted p=0.02). The additional adjusted post-hoc analysis did not show any difference between the two treatment groups (33 C/36 C p=0.94) but statistically significant differences between the STEMI-controls and the 33°C and 36°C groups respectively (33 C/STEMI-controls p <0.001, 36 C/STEMIcontrols p <0.001). Supplemental Table 3 shows estimated means (SDMT z-scores) for the adjusted analysis.
Education and age but not gender had a significant effect on cognitive outcome in all adjusted analyses (FAB, RBMT). The patients in the 33°C-group were older and had a lower education level but adjustment for these small differences in baseline variables did not significantly alter the results of the comparisons between the two temperature groups. Both unadjusted and adjusted analyses showed very similar results with no significant differences between the two temperature groups. Cognitive impairment at similar levels as for the OHCA-population has been reported for ICU-treated patients suffering critical illness without primary brain injury. [25] [26] [27] Potential causal factors include age and disease-severity at baseline, use of sedatives and analgesics in the ICU, neuro-inflammatory processes, systemic factors (e.g. hypotension, hypo/hyper glycaemia) and psychological morbidity (e.g. anxiety, depression and posttraumatic stress). 26, 27 The duration of delirium seems to play an important role for post-ICU cognitive impairment 25 but the causality remains unexplained. Most studies of cognition in critically ill patients are hampered by similar methodological weaknesses as most OHCA-studies, including lack of objectively measured baseline-data and matched controls.
Due to the unexpected nature of a cardiac arrest, baseline cognitive performance is cardiac arrest patients, except in the test of attention and processing speed (SDM MT) T T), , , wh wh wher er ere e e f cardiac arrest survivors performed significantly poorer. This is a novel finding suggesting that ot the he er r r fa fa fa t ct ctor or ors s t than an n t t the h brain injury related to the ca ca c r rd diac arrest may ay y be of of of m major importance to ex xp pl lai a n cognit tiv ive e e i im imp pa air ir rme me ment nt nt i i in n OH OH OHC CA A--survi vi v v v vors s s.
Co Cogn gn gni it itiv ive e e i im impa p pair ir rme m nt nt nt a at t t si si simi mi m la la ar r le le leve ve vels s s a a as s fo for r th th he e OH OH OHCA CA CA-p -p -pop op opul ula a ati io ion n ha ha has s s be be een en en r re ep epor orte te ed fo for CU-treated pa pa pati ti tien en nts ts ts s suf uf ufferi ri ring ng ng c c cri ri r ti ti t ca ca cal il il illn ln lnes es ess s s wi wi with th hou ou out t t pr pr rim im imar ar ary y y br br brai a a n n n in in inju ju jury ry ry. . 25 25 25-27 27 27 P P Pot ot o en en enti tial causal difficult to assess. Assigning all cognitive impairment in OHCA-survivors to the brain injury related to the cardiac arrest can be misleading since cognitive impairment may be present prior to the arrest due to age and/or cardiovascular risk factors. 28 A control group addressing this important confounder was included in only a minority of previous studies. These investigations all reported more cognitive problems in the OHCA-group but milder cognitive impairment was detected among 18-37% of control patients. [12] [13] [14] 29 We used a control group well matched regarding known risk factors for cognitive decline. 28 When comparing the cardiac arrest patients with the STEMI-controls the residual cognitive impairment attributable to the OHCA was less than previously reported. 11 Impaired memory was almost equally common for STEMI-controls and less than 50% of the detected executive dysfunction may be related to the OHCA.
Correspondingly, for many years a substantial cognitive decline following coronary by-passgrafting (CABG) was reported. However, as investigators included adequately disease-matched controls without CABG a similar decline was found. 30, 31 CABG patients have resembling comorbidities as OHCA-patients and it is reasonable to assume that cognitive decline in these groups may be more influenced by age and underlying vascular disease rather than the consequence of a specific intervention or event. Diabetes and hypertension are associated with cognitive decline in late-middle age. 28, 32, 33 and to disregard these co-morbidities may lead to an overestimation of cognitive impairment associated with any cardiac disease. 31 However, the lack of a healthy control group limits our conclusions regarding the possible contribution of the STEMI to cognitive disability in our control population, something that needs to be addressed in future studies.
There are an extensive number of cognitive tests available and to select the most accurate tests to evaluate patients surviving an OHCA is challenging as no gold standard tests or and less than 50% of the detected executive dysfunction may be related to the OH OH HCA CA C . .
Correspondingly, for many years a substantial cognitive decline following coronary by-passgr graf af fti ti ting ng ng ( ( (CA CA CAB BG BG) ) ) w wa was reported. However, as inve ve vest sti igators included ed e ade de equ qu quately disease-matched co on nt ntro r ls witho out ut C C CAB AB BG G a a s si simi mi mila lar r de de decl clin ine e wa a as fou un nd d d. 30 , 0, , 31 31 1 C C CA AB BG G G p pati tien en nts s s h ha av ave e e re res s semb mb mbli l l ng ng ng co omo mo morb rb rbid idit it tie ie ies s as as O O OHC HC CA A-A-pa pati ti ien en e ts ts ts a a and nd n i it t t is is is r r re e easo so sona na nabl bl le e t to to a a ass ss ssum um me e e t th that at at c co o ogn ni niti tiv ve ve d d dec ec cli li in n ne i i in th thes es se groups may y b be e e mo mo more re re i inf nf nflu l en en ence ce c d d d by by by a a age ge e a a and nd nd u u und nd nde erl rl r yi yi ying ng n v v vas as ascu cu cula la ar r r di d d se se seas as ase e e ra ra rath th ther er r t tha ha han n n th th he e combination of tests currently exists. We chose instruments with acceptable levels of reliability and validity, translated to the languages of the participating countries and without too specific demands on the examiner or patients in order to enhance inclusion and target the cognitive functions known to be the most commonly affected after OHCA. 11 Although translated, a limitation is that most assessments we use lack further cross-validation studies.
RBMT is a sensitive test to evaluate mild cognitive impairment. 34, 35 Criticisms that it may be insensitive for very mild impairment have led to the updated RBMT-3 version, which
was not available when the current study was commenced. The mean RBMT-score for the OHCA-survivors in our study was better than previously reported (17.4-18.1) 13, 36 but lower compared to a healthy sample (22.2). 19 A normal memory score was obtained by 50% of the patients in our study compared to the previously described 20% for OHCA survivors. 13, 36 Although this might be an effect of improvements in care 37, 38 it may also reflect the much larger sample size in our study. Moreover, it is unlikely that the 14 (4%) missing eligible patients with a poor outcome would affect this results if included together with the 19 (6%) missing patients with a good outcome.
Frontal/executive impairment has been described as one of the most common findings in OHCA-survivors, particularly in the severely brain injured patients. 39 Executive functions such as planning, flexibility and abstract thinking are important factors for the ability to learn strategies and adjust to new circumstances, which may be crucial for the patient's recovery and ability to return to work. In our study executive dysfunction was less common than memory problems and diminished processing speed although 20% of the OHCA-patients had a low score.
As a limitation, we recognize that the prevalence of frontal impairment in our study may have been underestimated since we used only a short screening battery (FAB). Several validation compared to a healthy sample (22.2). 19 A normal memory score was obtained by y 5 50% 0% 0% o o of f f th th the e e patients in our study compared to the previously described 20% for OHCA survivors. 13, 6 Al Al Alth th tho ou ough gh gh t t thi h h s mi mi mig ght be an effect of improvem men en ents s s in care 37, 38 it t ma m y y al al also s reflect the much a arg g ger e sample si si iz z ze in n o o our r r st st stud ud udy y y. M M Mor or reo eo ov ve er, i it t t i is s un n nli ik kely ly y t tha ha at th th t e e 14 14 4 ( (4% 4% 4%) ) mi mi iss ss sin ing g el el elig ig igib ib ible e e p pa at atie e ents wi wi ith th th a a a p p poo oor r r o ou outc tcom om ome e wo wo woul uld d af af a fe fe fect ct ct t t thi h his s re re esu su sult lt lts if if if i inc n nclu lu l d de ded d d to to toge ge eth th the e er w w wit it i h h h th h he e 1 19 19 ( ( (6% 6% %) ) ) mi miss ssin in i g g patients with h a a a go go good od od o o out ut utco come me me. . Although reduction in processing speed was not uncommon among the STEMI-controls it was much more prevalent among the OHCA-patients measured with the SDMT-test. A decreased processing speed and attention deficit was found in more than 50% of the OHCApatients and may affect the patient's ability to learn and focus on new information and slow the retrieval of stored memories. These functions are the most sensitive to brain injury of any cause. 22 However, when testing memory function with the RBMT, OHCA-patients and STEMIcontrols performed similarly, indicating that the consequences of a lower process speed for everyday life remains uncertain and that decreased processing speed may be compensated for by e.g. staying focused and spending more time on the task. This may explain why subjective memory complaints are more common among younger OHCA-survivors 14 with higher levels of activities and demands. Lower processing speed is closely associated with fatigue, which is an important limitation for return to work and participation in leisure activities. 42 In our adjusted analyses there was a tendency towards worse cognitive outcome for Lo Lo owe we wer pr pr proc oc oces e e si si ing ng ng s s spe pe peed ed d i i is s s cl cl clos osel el ely y y as as asso so soci ci ciat ted ed ed w w wit it ith h h fa fa f ti i igu gu gue, e, e w w whi h ch is an missing data describing only a selected sample of survivors 7, 8, 10, 13, 14, 43, 44 . Among the strengths of the current study is the high inclusion ratio, but also that we were able to obtain information on patients who chose not to participate in the study but consented to the main trial. These data were used to perform multiple imputations. The fact that the imputed data set consisted of patients with worse outcome than the complete cases emphasizes the importance of this statistical approach.
As a limitation we recognize as a potential source of bias that STEMI-controls may have been more prone to participation if they experienced subjective cognitive complaints, or conversely that patients eligible with more severe problems may have declined to a higher extent.
Only a small group of OHCA survivors (<10%) will survive with a severe brain injury and much of the milder cognitive impairment described are likely not attributable to the OHCA alone. The cognitive impairment must be understood not only in a context of the increased risk for ischemic brain injury due to the cardiac arrest, but also in relation to age, previous cardiovascular disease and factors of suffering a critical-illness and prolonged ICU-care.
Conclusion
We found no differences in cognitive outcome between out-of-hospital cardiac arrest survivors managed with targeted temperature management at 33°C or 36°C. Half of the cardiac arrest patients had cognitive impairment that was mostly mild and more often affected attention and processing speed. Although cognitive impairment was common among cardiac arrest survivors the impact of brain injury related to the cardiac arrest may have been overestimated as disease matched STEMI-control patients were found to have similar levels of impairment.
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-Variables used for multiple imputations for cardiac arrest patients were: age, sex, education, randomization code, country, previous arterial hypertension, known diabetes, previous ischemic heart disease, previous acute myocardial infarction, previous arrhythmia, known neurological disease, cardiac arrest location, bystander witnessed arrest, bystander cardio-pulmonary resuscitation, bystander defibrillation, use of automatic compression/decompression, number of defibrillations, pre-hospital intubation, time to ROSC (return of spontaneous circulation), days at hospital, days from event to follow-up, intervention with CABG, MMSE sum score, CPC at 180 days, mRS at 180 days, HADS anxiety sum scores, HADS depression sum scores, IQCODE sum scores, Two Simple Questions 1,1b,2, , FAB sum score, RBMT profile sum score, SDMT z-score.
-Variables used for multiple imputations for controls with incomplete test results: age, sex, education, , country, previous arterial hypertension, known diabetes, previous ischemic heart disease, previous acute myocardial infarction, previous arrhythmia, known neurological disease, days at hospital, days from event to follow-up, intervention with CABG, MMSE sum score, CPC at 180 days, mRS at 180 days, HADS anxiety sum scores, HADS depression sum scores, IQCODE sum scores, Two Simple Questions 1,1b,2, , FAB sum score, RBMT profile sum score, SDMT z-score.
-Non-normally distributed imputation variables were prevented by using predictive mean matching.
-Ten imputed datasets were created. A total run length of 20 iterations was used to obtain convergence.
-Multiple imputations were performed in the R statistical software 3.1.0.using the mice 2.21 package. 
Supplemental Table 3. Estimated means for the Symbol Digit Modalities Test (SDMT)
*Estimated means (± 95% confidence interval) are presented from the analysis of SDMT including covariates (gender, country). †Estimated mean scores are presented as z-scores (age and education adjusted) with pre-specified levels of impairment defined as: < -1 SD = low score, < -1.5 SD used as a cut-off for possible cerebral dysfunction and < -2 very low scores. ‡Overall p-values from post-hoc analyses: 33C vs.36C p=0.94, 33C vs. controls p=0.001 and 36C vs. controls p=0.001. R-square (adjusted, including intercept) =8.2%.
